146 related articles for article (PubMed ID: 33819548)
21. Tartrazine-induced chromosomal aberrations in mammalian cells.
Patterson RM; Butler JS
Food Chem Toxicol; 1982 Aug; 20(4):461-5. PubMed ID: 6890025
[TBL] [Abstract][Full Text] [Related]
22. The role of invariant natural killer T cells in experimental xenobiotic-induced cholestatic hepatotoxicity.
Nong C; Zou M; Xue R; Bai L; Liu L; Jiang Z; Sun L; Huang X; Zhang L; Wang X
Biomed Pharmacother; 2020 Feb; 122():109579. PubMed ID: 31794947
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes.
Oorts M; Baze A; Bachellier P; Heyd B; Zacharias T; Annaert P; Richert L
Toxicol In Vitro; 2016 Aug; 34():179-186. PubMed ID: 27046439
[TBL] [Abstract][Full Text] [Related]
24. Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids As a Marker of Cholestatic Drug Potential.
Burban A; Sharanek A; Humbert L; Eguether T; Guguen-Guillouzo C; Rainteau D; Guillouzo A
Toxicol Sci; 2019 Apr; 168(2):474-485. PubMed ID: 30629237
[TBL] [Abstract][Full Text] [Related]
25. Effect of drug transporter pharmacogenetics on cholestasis.
Dietrich CG; Geier A
Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1533-51. PubMed ID: 25260651
[TBL] [Abstract][Full Text] [Related]
26. Network-based Assessment on Chemical-induced Cholestatic Liver Injury.
Chen Q; Zheng J; Shao Y; Ai N; Wu L; Liu Y; Lu X; Fan X
Curr Top Med Chem; 2016; 16(30):3668-3677. PubMed ID: 27334198
[TBL] [Abstract][Full Text] [Related]
27. Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration.
Sakai Y; Okumura H; Iwao T; Watashi K; Ito K; Matsunaga T
Toxicol In Vitro; 2019 Dec; 61():104619. PubMed ID: 31394163
[TBL] [Abstract][Full Text] [Related]
28. Prediction of the Clinical Risk of Drug-Induced Cholestatic Liver Injury Using an In Vitro Sandwich Cultured Hepatocyte Assay.
Susukida T; Sekine S; Nozaki M; Tokizono M; Ito K
Drug Metab Dispos; 2015 Nov; 43(11):1760-8. PubMed ID: 26329788
[TBL] [Abstract][Full Text] [Related]
29. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
[TBL] [Abstract][Full Text] [Related]
30. Transcriptome analysis to assess the cholestatic hepatotoxicity induced by Polygoni Multiflori Radix: Up-regulation of key enzymes of cholesterol and bile acid biosynthesis.
Jiang LL; Zhao DS; Fan YX; Yu Q; Lai YS; Li P; Li HJ
J Proteomics; 2018 Apr; 177():40-47. PubMed ID: 29438852
[TBL] [Abstract][Full Text] [Related]
31. Predicting drug-induced cholestasis: preclinical models.
Petrov PD; Fernández-Murga ML; López-Riera M; Goméz-Lechón MJ; Castell JV; Jover R
Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):721-738. PubMed ID: 29888962
[TBL] [Abstract][Full Text] [Related]
32. In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist.
Vinken M
Arch Toxicol; 2018 May; 92(5):1909-1912. PubMed ID: 29574564
[No Abstract] [Full Text] [Related]
33. Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability.
Hendriks DF; Fredriksson Puigvert L; Messner S; Mortiz W; Ingelman-Sundberg M
Sci Rep; 2016 Oct; 6():35434. PubMed ID: 27759057
[TBL] [Abstract][Full Text] [Related]
34. On the mutagenicity of tartrazine (FD&C Yellow No 5).
Combes RD
Arch Toxicol; 1986 May; 59(1):68-70. PubMed ID: 3741148
[No Abstract] [Full Text] [Related]
35. Electrochemical sensor based on graphene and mesoporous TiO2 for the simultaneous determination of trace colourants in food.
Gan T; Sun J; Meng W; Song L; Zhang Y
Food Chem; 2013 Dec; 141(4):3731-7. PubMed ID: 23993542
[TBL] [Abstract][Full Text] [Related]
36. Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury.
Malinen MM; Ali I; Bezençon J; Beaudoin JJ; Brouwer KLR
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G597-G609. PubMed ID: 29420067
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes.
Parmentier C; Couttet P; Wolf A; Zaccharias T; Heyd B; Bachellier P; Uteng M; Richert L
Arch Toxicol; 2017 Aug; 91(8):2879-2893. PubMed ID: 28188341
[TBL] [Abstract][Full Text] [Related]
38. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
[TBL] [Abstract][Full Text] [Related]
39. Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury.
Vinken M; Landesmann B; Goumenou M; Vinken S; Shah I; Jaeschke H; Willett C; Whelan M; Rogiers V
Toxicol Sci; 2013 Nov; 136(1):97-106. PubMed ID: 23945500
[TBL] [Abstract][Full Text] [Related]
40. Electrochemical fabrication of a novel ZnO/cysteic acid nanocomposite modified electrode and its application to simultaneous determination of sunset yellow and tartrazine.
Dorraji PS; Jalali F
Food Chem; 2017 Jul; 227():73-77. PubMed ID: 28274460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
